Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • MOBIC ® - Dysmenorrhea
    Clinical Study Number 107.191
    Study Indication Dysmenorrhea
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase IIb
    Study Title

    Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of dysmenorrhea.

    Study Document
    Trial synopsis 107.191 english